66 /100
HIGH RISK
Score updated Jul 13, 2026

ONCO — Onconetix, Inc. Dilution Risk Tracker

Track ONCO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ONCO — Get alerts when the score changes →

As of July 13, 2026, Onconetix, Inc. (ONCO) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. Onconetix, Inc. has a market capitalization of $1.38M, 11.46M shares outstanding, 6 institutional holders tracked. Key dilution vectors include shelf registration capacity of $25.00M, 3.7K outstanding warrants, approximately 22 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
25
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
38%
🔁 Convertible Conversion 60%
• Major convertible overhang: 330% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 20%
• Active shelf registration ($25M, 1817% of market cap)
📉 Score Deterioration 10%
• Score in HIGH risk zone (66/100)
🔔 Track ONCO — Get forecast alerts →

💹 Market Data

Market Cap$1.38M
Shares Outstanding11.46M
FloatN/A
Cash$25.75M
Debt$289.9K
Short InterestN/A

🏛 Institutional Holdings

6 institutional holders · 12.2K shares
#1 DRW Securities, LLC 7.8K shares
#2 Xtx Topco Ltd 2.2K shares
#3 UBS Group AG 1.8K shares
+ 3 more holders Sign up free to view →

📉 Short Interest

Short Interest61.6K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 23, 2025
S-1 SHELF Apr 28, 2026
4 INSIDER TRANSACTION Apr 22, 2026
4 INSIDER TRANSACTION Apr 21, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ONCO Shareholders

Onconetix, Inc. (ONCO) has a DilutionScore of 66/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

The most significant dilution vector for ONCO is its shelf registration capacity of $25.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely.

DilutionWatch tracks over 25 SEC filing types for ONCO in real-time, scanning EDGAR every 60 seconds. A recent S-3 or registration statement filing appears in ONCO's filing history — this warrants monitoring for subsequent prospectus supplements (Form 424B), which indicate active capital raising. The DilutionWatch screener shows real-time score changes for ONCO alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding Shelf Registrations →
Track ONCO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ONCO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ONCO
📊 ONCO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ONCO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.